Habil Khorakiwala says: “We have earlier signed an agreement on a profit-sharing basis for contract manufacturing with Serum Institute to m...

The experience with Covid vaccine development has provided India a unique opportunity to burnish its credentials as a global leader in the ...

The QIDP status is granted to drugs that are effective against a set of multi-drug resistant pathogens identified by the Centre for Disease...

"With the new facility in the Middle East, we aim to focus on our commitment to developing NCEs to fight the health issues," Wockhardt Foun...

The renewed optimism in the global outlook for anti-infective products vindicates the company’s long-term strategy.

QIDP status is granted to drugs identified by Centre for Disease Control, US, that act against pathogens which have a high degree of unmet ...

Pharma firm Wockhardt will continue to strengthen its R&D capabilities to develop innovative and technologically advanced medicines, a top ...

Wockhardt today said a product from its new drug discovery programme, which aims to treat pneumonia, has received QIDP status from the US h...

This is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued.

The 50-share NSE Nifty index breached the 8,000-mark for the first time ever in trade on Monday and BSE Sensex logged a new peak of 26,854....

The 50-share Nifty index surged over 40 points to hit its fresh record high of 8,007.95, led by gains in NTPC, Coal India, Hindalco, L&T an...

This is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued here.

Two drugs - WCK 771 and WCK 2349 - have received QIDP status, which allows fast-track review of the drug application by the USFDA.